|
× |
 |
Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Recursive Subsetting to Identify Patients in the STAR*D: A Method to Enhance the Accuracy of Early Prediction of Treatment Outcome and to Inform Personalized Care PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Narcissistic Personality Disorder: Results From the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions PDF |
$40.00 |
|
$40.00 |
|
× |
|
Mental Illness and Psychotropic Drug Use Among Prescription Drug Overdose Deaths: A Medical Examiner Chart Review PDF |
$40.00 |
|
$40.00 |
|
× |
|
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Role of Consultation-Liaison Psychiatry in the COVID-19 Pandemic PDF |
$40.00 |
|
$40.00 |
|
× |
|
Weaning From Exogenous Sedation in the Era of COVID-19 Infection: Recommendations for Sedation and Its Discontinuation PDF |
$40.00 |
|
$40.00 |
|
× |
|
Acetyl-l-Carnitine and New-Onset Psychosis During the COVID-19 Pandemic PDF |
$40.00 |
|
$40.00 |
|
|
